Table 2. Overall survival for all histologic subtypes.
| Overall survival | TC | GCC | NEC | MANEC | Adenocarcinoma | 
|---|---|---|---|---|---|
| 1-year OS | 97.4% | 95.5% | 92.9% | 88.6% | 86.3% | 
| 2-year OS | 96.8% | 90.5% | 88.0% | 77.0% | 73.5% | 
| 3-year OS | 95.7% | 85.9% | 84.8% | 73.1% | 65.7% | 
| 4-year OS | 95.7% | 82.0% | 84.8% | 62.2% | 57.6% | 
TC, typical carcinoids; GCC, goblet cell carcinoids; NEC, neuroendocrine carcinomas; MANEC, mixed adenoneuroendocrine carcinomas.